2010
DOI: 10.1016/j.bmc.2010.03.052
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and biological activity of N4-phenylsubstituted-6-(2,4-dichloro phenylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines as vascular endothelial growth factor receptor-2 inhibitors and antiangiogenic and antitumor agents

Abstract: A series of eight N 4 -phenylsubstituted-6-(2,4-dichlorophenylmethyl)-7H-pyrrolo [2,3-d] pyrimidine-2,4-diamines 8-15 were synthesized as vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors with varied substitutions in the phenyl ring of the 4-anilino moiety. In addition, five N 4 -phenylsubstituted-6-phenylmethylsubstituted-7H-pyrrolo[2,3-d]pyrimidin-4-amines 16-20 were synthesized to evaluate the importance of the 2-NH 2 moiety for multiple receptor tyrosine kinase (RTK) inhibition. Cyclocon… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
21
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 33 publications
(21 citation statements)
references
References 45 publications
0
21
0
Order By: Relevance
“…We also explored the role of apoptosis on cancer cell lines. Pyrrolo[2,pyrimidine is known to have a broad spectrum of biological activities, including antitumor activity (Jung et al, 2009;Abou El Ella et al, 2007;Gangjee et al, 2010), so some new 2-aryl-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-ones have been prepared through cyclocondensation of 2-amino-1H-pyrrole-3carboxamides with aromatic aldehydes, followed by air oxidation in the presence of 3-methyl-1-(4-sulfonic acid) butylimidazolium hydrogen sulfate [(CH 3 ) 4 SO 3 HMIM] [HSO 4 ], a Brønsted-acid ionic liquid, as a green, reusable catalyst in solvent-free conditions (Davoodnia et al, 2010) (Scheme 1).…”
Section: Introductionmentioning
confidence: 99%
“…We also explored the role of apoptosis on cancer cell lines. Pyrrolo[2,pyrimidine is known to have a broad spectrum of biological activities, including antitumor activity (Jung et al, 2009;Abou El Ella et al, 2007;Gangjee et al, 2010), so some new 2-aryl-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-ones have been prepared through cyclocondensation of 2-amino-1H-pyrrole-3carboxamides with aromatic aldehydes, followed by air oxidation in the presence of 3-methyl-1-(4-sulfonic acid) butylimidazolium hydrogen sulfate [(CH 3 ) 4 SO 3 HMIM] [HSO 4 ], a Brønsted-acid ionic liquid, as a green, reusable catalyst in solvent-free conditions (Davoodnia et al, 2010) (Scheme 1).…”
Section: Introductionmentioning
confidence: 99%
“…In 2010 in an attempt to structurally design either a dual EGFR/VEGFR-2 inhibitor or even a selective VEGFR-2 inhibitor, (Compound 43) was previously synthesized as multiple RTK inhibitor, and the VEGFR-2 inhibitor (Compound 47), were chosen for further evaluation and showed significant inhibition of tumor growth, angiogenesis and metastasis. 136 …”
Section: Pyrrolopyrimidines As Multiple Receptor Tyrosine Kinase Inhimentioning
confidence: 99%
“…The well known diverse biological activities of compounds containing pyridines and pyrimidines as components of fused azines [8][9][10][11][12][13][14][15][16]21,[22][23][24][25][26][27][28] prompted us to test and study the antibacterial activities of some of the newly synthesised products. Table 1 shows that most of the tested compounds had moderate to high activity against all four microorganisms.…”
Section: Bioactivity Of Synthesised Compoundsmentioning
confidence: 99%